key: cord-0884754-t0xuc3tl
authors: Sabioni, Letícia; De Lorenzo, Andrea; Lamas, Cristiane; Muccillo, Fabiana; Castro-Faria-Neto, Hugo Caire; Estato, Vanessa; Tibirica, Eduardo
title: Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis
date: 2020-12-03
journal: Microvasc Res
DOI: 10.1016/j.mvr.2020.104119
sha: a20ce77930d732bc5bec7d03f4ec30148bed2863
doc_id: 884754
cord_uid: t0xuc3tl

Background Microvascular dysfunction, serum cytokines and chemokines may play important roles in pathophysiology of coronavirus disease 2019 (COVID-19), especially in severe cases. Methods Patients with COVID-19 underwent non-invasive evaluation of systemic endothelium-dependent microvascular reactivity - using laser Doppler perfusion monitoring in the skin of the forearm - coupled to local thermal hyperemia. Maximal microvascular vasodilatation (44° C thermal plateau phase) was used as endpoint. A multiplex biometric immunoassay was used to assess a panel of 48 serum cytokines and chemokines. Severe COVID-19 (S-COVID) was defined according to WHO criteria, while all other cases of COVID-19 were considered mild to moderate (M-COVID). A group of healthy individuals who tested negative for SARS-CoV-2 served as a control group and was also evaluated with LDPM. Results Thirty-two patients with COVID-19 (25% S-COVID) and 14 controls were included. Basal microvascular flow was similar between M-COVID and controls (P=0.69) but was higher in S-COVID than in controls (P=0.005) and M-COVID patients (P=0.01). The peak microvascular vasodilator response was markedly decreased in both patient groups (M-COVID, P=0.001; S-COVID, P<0.0001) compared to the healthy group. The percent increases in microvascular flow were markedly reduced in both patient groups (M-COVID, P<0.0001; S-COVID, P<0.0001) compared to controls. Patients with S-COVID had markedly higher concentrations of dissimilar proinflammatory cytokines and chemokines, compared to patients with M-COVID. Conclusions In patients with COVID-19, especially with S-COVID, endothelium-dependent microvascular vasodilator responses are reduced, while serum cytokines and chemokines involved in the regulation of vascular function and inflammation are increased.

Coronavirus disease 2019, or COVID-19, is an acute viral illness caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV2) (Meyerowitz et al., 2020) . It has affected all regions of the world, and as of 23 rd November 2020, there have been 58,425,681 confirmed cases and 1,385,218 deaths, reported to the World Health Organization (WHO, 2020) . It is transmitted by respiratory droplets, with an R0 of 2-3, and has a mean incubation time of five days (Meyerowitz et al., 2020) . Most cases (80%), when symptomatic, present with fever and upper respiratory and gastrointestinal tract symptoms (Casas-Rojo et al., 2020; Richardson et al., 2020; Wu and McGoogan, 2020) , many of which with olfactory and gustatory dysfunctions (Passali and Bentivoglio, 2020) . Most importantly, around 15% of patients present a severe form of disease, that evolves over 7 to 10 days with dyspnea, a respiratory rate of over 30/min, blood oxygen saturation less than 93%, partial pressure of arterial oxygen to inspired oxygen fraction ratio <300, and/or lung infiltrates occupying over 50% within 24 to 48 hours; around 5% become critically ill, with respiratory failure, septic shock, and/or multiple organ dysfunction (Grasselli et al., 2020; Richardson et al., 2020; Wu and McGoogan, 2020) . This imposes a heavy burden on intensive care beds, even in highincome countries, as recognized early on (Grasselli et al., 2020) .

Two main features are noticed in the severe form: intense systemic inflammation and hypercoagulability (Connors and Levy, 2020) . The expression "cytokine storm" has been proposed to depict this clinical situation (Mehta et al., 2020; Ruan et al., 2020) . A multicenter study in 150 severe COVID-19 cases showed that high levels of ferritin and IL-6 were associated to death (Ruan et al., 2020) . High C-reactive protein levels and ddimer were also related to disease severity (Mehta et al., 2020) .

Therapeutic measures to address the systemic inflammatory syndrome depicted have been studied. So far, there is an established role for steroids. They have been used with success in the severe forms of pulmonary disease, with a significant impact on decreasing the need for invasive ventilation and death, and rapid improvement in PaO 2 /FiO 2 and a drop in CRP levels (Salton et al., 2020) . The benefit of using steroids has been proved by a randomized trial that was conducted with a total of 2,104 patients given dexamethasone 6 mg once per day for ten days and compared with 4,321 patients randomized to usual care alone (Horby et al., 2020) . Among the patients who received usual care alone, 28-day mortality was highest in those who required ventilation (41%), intermediate in those patients who required oxygen only (25%), and lowest among those who did not require any respiratory intervention (13%). Dexamethasone reduced deaths by one-third in ventilated patients and by one fifth in other patients receiving oxygen only. However, there was no benefit among those patients who did not require respiratory support (Horby et al., 2020) .

Tocilizumab, a humanized monoclonal antibody that binds human interleukin-6 receptors, has a less clear role in severe COVID-19, as results from randomized trials reported to have failed to show mortality benefit at 28 or 30 days (Parr, 2020) .

Since the beginning of the pandemic, a large number of studies have attempted to investigate the pathophysiology, clinical course and treatment options of COVID-19 (Aguilar et al., 2020; Petrilli et al., 2020; Psotka et al., 2020; Stratton et al., 2020) . endothelial cells are a common link between the invasion of the body by SARS-CoV-2 and pre-existing cardiometabolic diseases Tibirica and De Lorenzo, 2020a; Tibirica and De Lorenzo, 2020b) . In addition, patients diagnosed with moderate or severe COVID-19 present increased levels of proinflammatory cytokines, particularly interleukin-6 and tumor necrosis factor-α (Chen et al., 2020a) . Cytokine release syndrome ("cytokine storm"), which is characterized by a massive increase in the levels of proinflammatory cytokines, is known to be the major cause of morbidity and mortality in patients infected by SARS-CoV-2 (Chen et al., 2020a) .

Clinical studies on microcirculatory physiology have been performed for a long time, in the context of several conditions (Roustit and Cracowski, 2012) , and using different methods (Cracowski and Roustit, 2016) . Of note, the cutaneous microcirculation is an accessible and representative vascular bed that can be used for the evaluation of systemic microcirculatory flow and reactivity (Holowatz et al., 2008) .

Laser Doppler perfusion monitoring (LDPM) is a noninvasive method for the evaluation of systemic microvascular endothelial function, and LDPM has already proven useful in many clinical conditions (Turner et al., 2008) , including cardiovascular and metabolic diseases (de Moraes et al., 2016; Gomes et al., 2008; Kaiser et al., 2013) , rheumatologic diseases (Ruaro et al., 2017; Weibel et al., 2007) and circulatory shock (either septic or cardiogenic) (Mongkolpun et al., 2020; Orbegozo et al., 2018) . Most published data concerning LDPM have validated the site of the skin of the forearm for the measurements, which is more accessible and more representative of general skin microvascular function (Cracowski and Roustit, 2016) . Systemic microvascular reactivity can be evaluated using LDPM combined with cutaneous local thermal hyperemia (LTH), as the vasodilatory response in the skin due to LTH represents, fundamentally, endothelium-dependent microvascular reactivity (Roustit and J o u r n a l P r e -p r o o f Journal Pre-proof Cracowski, 2012; Ugenti et al., 2018) . In fact, LTH induces a biphasic curve of cutaneous microvascular vasodilation; the initial peak (2-5 minutes) represents the local sensory nerve axon reflex (Roustit and Cracowski, 2013) , while the second peak (15 minutes) characterizes the release of endothelial vasodilators, predominantly nitric oxide (Roustit and Cracowski, 2013) . This methodology has already been used in the description of endothelial dysfunction and altered microvascular reactivity in different cardiovascular and metabolic diseases, including arterial hypertension (Rossi et al., 2008; Ullyot, 1990; Virdis and Taddei, 2011) type 1 diabetes (Sorelli et al., 2019) , hypercholesterolemia (Holowatz and Kenney, 2011; Holowatz et al., 2011) polycystic ovary syndrome and metabolic syndrome (Ketel et al., 2008) . Furthermore, LTH has been used as a clinical surrogate marker in various diseases, such as Raynaud's phenomenon and systemic sclerosis (Boignard et al., 2005; Roustit et al., 2008) . In the present study, maximal endothelium-dependent microvascular vasodilatation (44°C thermal plateau phase) was measured during the last five minutes of the second peak of microvascular flow resulting from LTH (a representative example of the recordings is presented in Figure 1 ).

Given that the presence and intensity of systemic microvascular changes during the acute phase of COVID-19 may be related to disease progression and prognosis, the evaluation of microvascular reactivity in COVID-19 patients may offer relevant information. Thus, we used LDPM, which provides a noninvasive, simple and repeatable evaluation of tissue perfusion (Tibirica and De Lorenzo, 2020a) , combined with LTH, to compare the systemic microvascular flow and reactivity in patients with mild-to-moderate or severe COVID-19 with that in age-matched healthy volunteers who tested negative for SARS-CoV-2. We also evaluated the plasma levels of different cytokines and chemokines with pro-or anti-inflammatory effects or with biological

Patients with COVID-19 who were admitted to the National Institute of Cardiology, Ministry of Health, Rio de Janeiro, Brazil, were included after signing an informed consent form. A responsible family member signed the informed consent form when the patients were unable to sign it themselves. All the patients had underlying cardiac disease. The study was approved by the Institutional Review Board and was registered and made public at ClinicalTrials.gov (NCT4406545).

The patients had SARS-CoV-2, which was detected by RT-PCR analysis of nasopharyngeal swabs, and met the criteria for hospitalization either due to their underlying condition or due to COVID-19 (Berlin et al., 2020; Wiersinga et al., 2020) .

The demographic, clinical and laboratory data were recorded. The laboratory data included in this study were obtained within 24 h of the assessment of microvascular reactivity, and the serum cytokine levels were evaluated on the same day when LDPM was performed.

Severe COVID-19 (S-COVID) was defined according to the WHO criteria, while all the other cases of COVID-19 were considered mild to moderate (M-COVID) (https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-oncovid-19-final-report.pdf). Due to the very distinct characteristics and management (especially the need for vasoactive drugs), the groups were analyzed separately: patients without severe disease (M-COVID) and patients with severe disease (S-COVID).

A group of healthy volunteers (without chronic diseases or cardiac risk factors) was recruited from hospital staff members who tested negative for SARS-CoV-2. This group was also evaluated with LDPM and served as a control group. This group did not undergo cytokine assessment.

The evaluation of the microvascular flow and reactivity was performed within one week after admission, during the acute phase of disease, using a single-point laser Doppler perfusion monitoring (LDPM) system (Periflux 5001, Perimed, Järfälla, Sweden) to noninvasively measure systemic microvascular perfusion changes (in arbitrary perfusion units [APU=10 mV]), as previously described (Cracowski and Roustit, 2016; Salgado et al., 2014) , using heating laser probes (PF 457, Perimed). The probes were attached to the skin with adhesive tapes, thus limiting movement artifacts.

Moreover, patients were asked not to move during the recording period. After measuring the resting microvascular flow on the skin of the forearm for five minutes, the maximal microvascular vasodilatation was assessed using prolonged (20 minutes) local heating of the laser probe to 44°C (local thermal hyperemia, LTH, Figure 1 ), as previously described in detail (Salgado et al., 2014; Ugenti et al., 2018) . Maximal vasodilatation (44° C thermal plateau phase) corresponds to the mean microvascular flow during the last five minutes of the second peak. Data were digitized and stored on a computer and analyzed off-line with signal processing software (PeriSoft, Perimed, Järfälla, Sweden). We also compared the individual percentage increase of endotheliumdependent microvascular conductance ( Figure 2C ), to normalize the results to baseline values of microvascular flow, which is measure in arbitrary perfusion units.

Blood samples were collected from a peripheral vein and stored on ice. Plasma was obtained by centrifugation at 800 g for 15 min at 4°C, aliquoted, and stored at -70°C until the day of analysis. A multiplex biometric immunoassay, using fluorescently dyed microspheres conjugated to monoclonal antibodies specific for a target protein, was 

The results are presented as the mean ± SD or median (25 th -75 th percentiles) for the parametric or nonparametric parameters, respectively, according to the Saphiro-J o u r n a l P r e -p r o o f Journal Pre-proof followed by Tukey's multiple comparisons test. The cytokine and chemokine data were analyzed using the two-tailed unpaired Mann-Whitney test. Contingency tables were analyzed using chi-square tests. P values <0.05 were considered statistically significant.

All the statistical analyses were performed using Prism, version 7.0 (GraphPad Software

Inc. La Jolla, CA, USA).

J o u r n a l P r e -p r o o f

Thirty-two COVID-19 patients and 14 healthy volunteers were included. Table 1 depicts the demographic and clinical characteristics of these individuals. Twenty-four (75%) patients had mild-to-moderate disease and were managed in regular hospital beds, while 8 (25%) required admission to the ICU for mechanical ventilation and/or hemodynamic support. The mean age of the patients with M-COVID was 58.2 ± 14.1 years, and that of the patients with S-COVID was 65.6 ± 6.5 years; in these groups, 54%

and 100% of the patients were male, respectively.

Evaluation IL-1α is closely linked to the innate immune response and assists in host defense against infection (Dinarello, 2009) . Soluble IL-2Rα is found at high levels in the circulation of healthy individuals but is further increased in patients with infection, inflammation and autoimmune diseases (Damoiseaux, 2020) . Soluble IL-2Rα and IL-6 are significantly correlated with the severity of lung injury and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO 2 /FiO 2 ) in COVID-19 patients with pneumonia. In addition, IL-6 is considered an independent predictor of adverse prognosis in COVID-19 patients (Chen et al., 2020b; Ruan et al., 2020; Zhou et al., 2020) .

humans. Macrophage-derived IL-15 contributes with other monokines (especially IL-12) to the proinflammatory cascade leading to innate immune IFN-γ production (Fehniger and Caligiuri, 2001) .

Interferons are essential in the response to viral infections, and the IFN-α response in SARS-CoV has been demonstrated in ferrets (Danesh et al., 2011) .

MCP-1 were found to be elevated in COVID-19 patients who needed intensive care treatment (Liu et al., 2020; Wang et al., 2020) . -Santana et al., 2001) . MIP-1β is produced by human monocytes and dendritic cells upon different stimuli and is a chemoattractant for NK cells, recruiting them to inflammatory sites. NK cells have been associated with mild dengue (Azeredo et al., 2006) . In the study by Bozza et al. (Bozza et al., 2008) suggest that RANTES is involved in obliterative changes in the pulmonary arteries of patients with pulmonary arterial hypertension (Raucci et al., 2020) . In addition, studies have shown that RANTES inhibitors significantly decreased viremia in SARS-CoV-2 patients (Raucci et al., 2020) .

CTACK is constitutively expressed in normal skin and is upregulated in wound sites. This chemokine is elevated in the cerebrospinal fluid samples of HIV-1-positive patients and is correlated with nonneurological disorders (Kopf et al., 1996) . However, our study is the first to demonstrate the increase in the CTACK levels in patients with COVID-19. The significance of this finding has yet to be determined.

The complexity of the cytokine/chemokine responses in COVID-19 patients is noteworthy. Huang et al (Huang et al., 2020) showed that patients infected with SARS-CoV-2 had high levels of IL1, IFNγ, IP10, and MCP1, probably leading to activated T helper 1 (Th1) cell responses, and patients requiring ICU admission had higher concentrations of G-CSF, IP10, MCP1, MIP1, and TNFα than those not requiring ICU admission, suggesting that the cytokine storm was associated with disease severity.

However, COVID-19 patients also exhibited increased secretion of T helper 2 (Th2)

cytokines (e.g., IL-4 and IL-10), which suppress inflammation. This observation is consistent with our results, as anti-inflammatory cytokines such as IL-5, which has a very narrow set of cellular targets, such as human eosinophils, basophils and a subset of mast cells, and, thus far, has not been described in COVID-19 patients (Kopf et al., 1996) and IL-10, which play a central role in limiting the host immune response to pathogens, thereby limiting damage to the host (Iyer and Cheng, 2012) , were increased (although not significantly in the case of IL-10) in patients with S-COVID. Further studies may elucidate the interplay between proinflammatory/anti-inflammatory mediators, as well as their vascular effects, in COVID-19 patients.

Limitations to this study must be considered. The M-COVID and S-COVID groups are imbalanced for number, age and sex. This is due to the "real-world" nature of the study, which was performed with incoming patients amidst the COVID-19 pandemic; therefore, the differences reflect epidemiologic characteristics of the pandemic, such as the higher number of male patients with severe disease, as well as increased age in this subgroup.

In conclusion, endothelium-dependent microvascular vasodilator responses J o u r n a l P r e -p r o o f The results are presented as the mean ± SD or the median (25 th -75 th percentile) for values that follow or do not follow a Gaussian distribution, respectively (Shapiro-Wilk normality test). P-values were estimated using two-tailed unpaired Student's t tests (comparisons of two groups for parameters with Gaussian distribution), two-tailed unpaired Mann-Whitney tests (comparisons of two groups for parameters with non-Gaussian distribution), or chi-square (Fisher's exact test), for categorical parameters. The parameters evaluated in the three groups of individuals (M-COVID, S-COVID and HEALTHY) were analyzed using one-way ANOVA. The values are expressed as the medians (25 th to 75 th percentiles) and were analyzed using the two-tailed unpaired Mann-Whitney test.

J o u r n a l P r e -p r o o f 

Current Understanding of COVID-19 Clinical Course and Investigational Treatments

NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease

Severe Covid-19

Local hyperemia to heating is impaired in secondary Raynaud's phenomenon

Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity

Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry

Clinical and immunological features of severe and moderate coronavirus disease 2019

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Microvascular alterations in patients with SARS-COV-2 severe pneumonia. Ann Intensive Care

The IL-2 -IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor

Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation

Minimizing catecholamines and optimizing perfusion

Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases

Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases

Effects of non-supervised low intensity aerobic excise training on the microvascular endothelial function of patients with type 1 diabetes: a non-pharmacological interventional study

Immunological and inflammatory functions of the interleukin-1 family

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans

Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans

The human cutaneous circulation as a model of generalized microvascular function

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial

Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease

Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals

Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia

Comment to the article "Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection

Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel

Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication

Non-invasive assessment of skin microvascular function in humans: an insight into methods

Assessment of endothelial and neurovascular function in human skin microcirculation

Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques

Effectiveness of laser Doppler perfusion monitoring in the assessment of microvascular function in patients undergoing on-pump coronary artery bypass grafting

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Assessment of cutaneous microcirculation by laser Doppler flowmetry in type 1 diabetes

Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 -COVID-19

Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?

Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis

Microvascular endothelial dysfunction during cardiopulmonary bypass in surgery for correction of cyanotic and acyanotic congenital heart disease

Surgical standby for coronary angioplasty

How to evaluate microvascular organ damage in hypertension: assessment of endothelial function

Definition and Risks of Cytokine Release Syndrome in 11

Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics

Laser Doppler flowmetry for assessing localized scleroderma in children

WHO, Coronavirus disease 2019 (COVID-19) dashboard november 23rd

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Interleukin-12: Functional activities and implications for disease

The authors would like to thank Marcio Marinho Gonzalez for his excellent technical assistance with laser speckle recordings and Edson Fernandes de Assis for performing